Real-time pharmacokinetics guiding clinical decisions: phase I study of a weekly schedule of liposome encapsulated paclitaxel in patients with solid tumours
- 31 March 2004
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 40 (5), 681-688
- https://doi.org/10.1016/j.ejca.2003.11.027
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Pharmacological Effects of Formulation VehiclesClinical Pharmacokinetics, 2003
- Vascular permeability enhancement in solid tumor: various factors, mechanisms involved and its implicationsInternational Immunopharmacology, 2002
- Mechanism-Based Pharmacokinetic Model for PaclitaxelJournal of Clinical Oncology, 2001
- Liposomal cancer chemotherapy: current clinical applications and future prospectsExpert Opinion on Investigational Drugs, 2001
- Progress in the Development of Alternative Pharmaceutical Formulations of TaxanesInvestigational New Drugs, 2001
- Complement Activation-Related Pseudoallergy Caused by Liposomes, Micellar Carriers of Intravenous Drugs, and Radiocontrast AgentsCritical Reviews in Therapeutic Drug Carrier Systems, 2001
- Complement Activation by Cremophor EL as a Possible Contributor to Hypersensitivity to Paclitaxel: an In Vitro StudyJNCI Journal of the National Cancer Institute, 1998
- Paclitaxel-liposomes for intracavitary therapy of intraperitoneal P388 leukemiaCancer Letters, 1996
- Recent advances in liposomal drug-delivery systemsCurrent Opinion in Biotechnology, 1995
- Factors affecting microencapsulation of drugs in liposomesJournal of Microencapsulation, 1995